Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a human growth hormone presented as a solution for subcutaneous injection (pre‑filled pen) for subcutaneous use. It treats growth hormone deficiency in children and adults, Turner syndrome, Prader‑Willi syndrome, and growth failure associated with chronic renal insufficiency.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin Flexpro is a recombinant human growth hormone used in disorders where growth hormone pathways are deficient or impaired. - Growth hormone deficiency in children: supports normal linear growth and height development. - Growth hormone deficiency in adults: improves body composition, bone density and metabolic parameters. - Turner syndrome: promotes growth and development during puberty. - Prader‑Willi syndrome: increases height and helps improve body composition. - Chronic renal insufficiency associated growth failure: enhances growth velocity in affected children.

Norditropin Flexpro may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the injection site. - Headache: transient headache reported by some patients. - Joint stiffness: occasional stiffness in joints. - Edema: mild peripheral swelling. - Hyperglycemia: elevated blood glucose levels. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - Intracranial hypertension: severe headache, visual changes, nausea. - Slipped capital femoral epiphysis: hip pain and limited motion. - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Acceleration of tumor growth: potential rapid progression of existing malignancies.

Before initiating therapy, several precautions should be observed. - Monitor glucose levels: risk of hyperglycemia, especially in diabetic patients. - Assess for intracranial hypertension: watch for persistent headaches or visual disturbances. - Screen for malignancy: GH may accelerate growth of active tumors. - Evaluate thyroid function: GH can influence thyroid hormone metabolism. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Concurrent insulin therapy: may require dose adjustments due to altered glucose metabolism. - High‑dose glucocorticoids: can antagonize growth‑promoting effects. - Other growth factors (e.g., IGF‑1): risk of excessive IGF‑1 levels.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: monitor blood glucose and adjust therapy as needed. - Thyroid hormone replacement: may need dose modification. - Diuretics: can exacerbate edema, requiring clinical observation.